Estimating required information size by quantifying diversity in random-effects model meta-analyses

BMC Medical Research Methodology

Volumn 9, Issue , 2009, Pages

  Wetterslev, Jørn ^a   Thorlund, Kristian ^a   Brok, Jesper ^a   Gluud, Christian ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; META ANALYSIS; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; STATISTICS;

META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SAMPLE SIZE; STATISTICS AS TOPIC;

EID: 75649084582     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-9-86     Document Type: Article

References (37)

1. In the era of systematic reviews, does the size of an individual trial still matter? GH Guyatt EJ Mills D Elbourne, PLoS Medicine 2008 5 1 4 doi:10.1371/jounal.pmed.0050004. 10.1371/journal.pmed.0050004 18177203
2. Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. J Pogue S Yusuf, Controlled Clinical Trials 1997 18 580 93 10.1016/S0197-2456(97)00051-2 9408720
3. Overcoming the limitations of current meta-analysis of randomised controlled trials. J Pogue S Yusuf, Lancet 1998 351 9095 47 52 10.1016/S0140-6736(97)08461-4 9433436
4. How strong is the evidence for the use of perioperative beta-blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. PJ Devereaux WS Beattie PT Choi NH Badner GH Guyatt JC Villar, BMJ 2005 331 7512 313 21 10.1136/bmj.38503.623646.8F 15996966
5. Trial sequential analysis may establish when firm evidence is reached in a meta-analysis. J Wetterslev K Thorlund J Brok C Gluud, Journal of Clinical Epidemiology 2008 61 1 64 75 10.1016/j.jclinepi.2007.03.013 18083463
6. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Brok K Thorlund C Gluud J Wetterslev, Journal of Clinical Epidemiology 2008 61 8 763 9 10.1016/j.jclinepi.2007.10.007 18411040
7. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? K Thorlund PJ Devereaux Wetterslev G Guyatt JPA Ioannidis L Thabane LL Gluud B Als-Nielsen C Gluud, International Journal of Epidemiology 2008 Doi:10.1093/iej/dyn179.
8. Apparently conclusive meta-analyses may be inconclusive-Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. J Brok K Thorlund J Wetterslev C Gluud, International Journal of Epidemiology 2008 Doi:10.1093/iej/dyn188. 18824466
9. Meta-analysis, Simpson's paradox, and the number needed to treat. DG Altman JJ Deeks, BMC Medical Research Methodology 2002 2 3 10.1186/1471-2288-2-3 11860606
10. Quantifying heterogeneity in a meta-analysis. JP Higgins SG Thompson, Statistics in Medicine 2002 21 1539 1558 10.1002/sim.1186 12111919
11. AR Feinstein, Clinical Epidemiology: the Architecture of Clinical Research Philadelphia: W.B. Saunders 1985 166
12. S-C Chow J Shao H Wang, Sample Size Calculation in Clinical Research CRC, Taylor & Francis Group, Shein-Chung Chow, 2003 Chapter 8.8.1 204 206
13. MR Spiegel, Mathematical Handbook of Formulas and Tables Schaum's outline series, McGraw-Hill Book Company 1971 http://en.wikipedia.org/wiki/Chebyshev%27s-sum-inequality
14. Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. B Takouche C Cadarso-Suaréz D Spiegelman, American Journal of Epidemiology 1999 150 206 215 10412966
15. Meta-analysis in clinical trials. R DerSimonian NM Laird, Controlled Clinical Trials 1986 7 177 188 10.1016/0197-2456(86)90046-2 3802833
16. Antithrombin III in critically ill patients. A systematic review with meta-analysis and trial sequential analysis. A Afshari J Wetterslev J Brok AM Møller, BMJ 2007 335 7632 1219 20 10.1136/bmj.39398.682500.25 18037614
17. Gonadotrophin-releasing hormone antagonists for assisted conception. HG Al-Inany AM Abou-Settea M Aboulghar, Cochrane Database of Systematic Reviews 2006 3 D001750
18. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. RF Soll, The Cochrane Database of Systematic Reviews 1997 4 D000511 10.1002/14651858. C
19. Benefits and harms of perioperative beta-blockade. J Wetterslev AB Juul, Best Practice and Research of Clinical Anesthesiology 2006 20 285 302 10.1016/j.bpa.2005.10.006 (Pubitemid 43811939)
20. Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants. RG Bury D Tudehope, The Cochrane Database of Systematic Reviews 2000 2 D000405 DOI: 10.1002/14651858.CD000405. 10796202
21. Intravenous magnesium for acute myocardial infarction. J Li M Zhang M Egger, Cochrane Database of Systematic Reviews 2007 2 D002755
22. Perioperative oxygen fraction - effect on surgical site infection and pulmonary complications after abdominal surgery: a randomized clinical trial. Rationale and design of the PROXI-Trial. CS Meyhoff J Wetterslev LN Jorgensen SW Henneberg I Simonsen T Pulawska LR Walker N Skovgaard K Heltø P Gocht-Jensen PS Carlsson H Rask S Karim CG Carlsen FS Jensen LS Rasmussen the PROXI Trial Group, Trials 2008 9 1 58 10.1186/1745-6215-9-58 18945347
23. Bias in clinical intervention research. LL Gluud, American Journal of Epidemiology 2006 163 493 501 10.1093/aje/kwj069 16443796
24. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. AW Chan A Hrobjartsson MT Haahr PC Gøtzsche DG Altman, Journal of American Medical Association 2004 291 20 2457 2465 10.1001/jama.291.20.2457 (Pubitemid 38669189)
25. Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. AW Chan DG Altman, BMJ 2005 330 7494 753 10.1136/bmj.38356.424606.8F 15681569
26. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. L Wood M Egger LL Gluud KF Schulz P Jüni DG Altman C Gluud RM Martin AJ Wood JA Sterne, BMJ 2008 336 7644 601 5 10.1136/bmj.39465.451748.AD 18316340
27. Randomized trials stopped early for benefit: a systematic review. VM Montori PJ Devereaux NK Adhikari KE Burns CH Eggert M Briel G Guyatt, Journal of American Medical Association 2005 294 17 2203 2209 10.1001/jama.294.17.2203 (Pubitemid 41571138)
28. Strengths and limitations of meta-analysis: larger studies may be more reliable. MD Flather ME Farkouh JM Pogue S Yusuf, Controlled Clinical Trials 1997 18 6 568 579 10.1016/S0197-2456(97)00024-X 9408719
29. The design of multicentre trials. V Fedorov B Jones, Statistical Methods in Medical Research 2005 14 205 248 10.1191/0962280205sm399oa 15969302
30. Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis. S Bangalore J Wetterslev S Pranesh S Sawhney C Gluud FH Messerli, Lancet 2008 372 9654 1962 76 10.1016/S0140-6736(08)61560-3 19012955
31. C Jennison BW Turnbull, Group sequential methods with application to clinical trials Chapman & Hall/CRC 2000 Chapter III 49
32. A comparison of heterogeneity variance estimators in combining results of studies. K Sidik JN Jonkman, Statistics in Medicine 2007 30;26 9 1964 81 10.1002/sim.2688 (Pubitemid 46534087)
33. 2 in assessing heterogeneity may mislead. G Rücker Schwarzer JR Carpenter M Schumacher, BMC Medical Research Methodology 2008 8 79 doi:10.1186/1471-2288-8-79. 10.1186/1471-2288-8-79 19036172
34. Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. JP Higgins, International Journal of Epidemiology 2008 37 1158 1160 10.1093/ije/dyn204 18832388
35. Are large trials less reliable than small trials? Letter to the editor. G Rücker G Schwarzer JR Carpenter M Schumacher, Journal of Clinical Epidemiology 2009 62 886 889 10.1016/j.jclinepi.2009.03.007 19481419
36. Extreme between-study homoge-neity in meta-analyses could offer useful insights. JP Ioannidis TA Trikalinos E Zintzaras, Journal of Clinical Epidemiology 2006 59 10 1023 32 10.1016/j.jclinepi.2006.02.013 16980141
37. Uncertainty in heterogeneity estimates in meta-analyses. JP Ioannidis NA Patsopoulos E Evangelou, BMJ 2007 335 7626 914 6 10.1136/bmj.39343.408449.80 17974687